Contraceptive prevalence, any modern method in Maldives
Maldives: Contraceptive prevalence, any modern method was 14.9% in 2017. ▼ Falling
Contraceptive prevalence, any modern method in Maldives, 1991–2017
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
Maldives recorded 14.9% for contraceptive prevalence, any modern method in 2017. That is the lowest value across all 5 years on record.
The figure is down 44.8% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Maldives peaked at 34.0% in 2004 and was at its lowest, 14.9%, in 2017.
That places Maldives 106th out of 113 countries with data for 2017, putting it in the bottom quarter.
Contraceptive prevalence, any modern method in Maldives, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1991 | 19.0% | — |
| 1999 | 33.0% | +73.7% |
| 2004 | 34.0% | +3.0% |
| 2009 | 27.0% | -20.6% |
| 2017 | 14.9% | -44.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 26.0% | 19.0% | 33.0% | 2 |
| 2000s | 30.5% | 27.0% | 34.0% | 2 |
| 2010s | 14.9% | 14.9% | 14.9% | 1 |
Countries ranked near Maldives
More health data for Maldives
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -2.69 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,560 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.2 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0264 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.8 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Maldives?
- Contraceptive prevalence, any modern method in Maldives was 14.9% in 2017, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Maldives?
- The highest recorded value was 34.0% in 2004.
- What is the lowest contraceptive prevalence, any modern method recorded in Maldives?
- The lowest recorded value was 14.9% in 2017.
- How does Maldives rank for contraceptive prevalence, any modern method?
- Maldives ranks 106th out of 113 countries with data for 2017.
- Is contraceptive prevalence, any modern method rising or falling in Maldives?
- Over the last ten years it is down 44.8%. The long-run trend across the full record is falling.
- Where does this Maldives data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.